1Ravenelle F, Vachon P, Rigby-Jones AE, et al. Anaesthet- ic effects of propofol polymeric micelle: a novel water sol- uble propofol formulation[J]. British Journal of Anaesthe- sia,2008, 101(2):186.
2Fechner J, Ihmsen H, Jeleazcov C, et al. Fospropofol diso- dium, a water-soluble prodrug of the intravenous anesthet- ic propofol (2,6-diisopropylphenol) [J]. Drugs, 2009, 18 (10):1 565.
3Zhou JX, Luo NF, Liang XM, et al. The efficacy and safe- ty of intravenous emulsified isoflurane in rats[J]. Anesthe- sia Analgesia, 2006,102( 1 ) : 129.
4Yang J, Chai YF, Gong CY, et al. Further proof that the spinal cord and not the brain, mediates the immobility pro- duced by inhaled anesthetics[J]. Anesthesiology, 2009,110 (3) :591.
5Chai YF, Yang J, Liu J, et al. Epidural anaesthetic effect of the 8 % emulsified isoflurane: a study in rabbits[J]. Brit- ish Journal of Anaesthesia, 2008,100( 1 ) : 109.
6Fast JP, Perkins M, Pearce RA, et al.Fluoropolymer-based emulsions for the intravenous delivery of sevolfurane[J]. Anesthesiology, 2008,109 (4) : 651.
7Schuttler J, Schwilden H. Modern Anesthetics[M].lst edi- tion .Springer, 2008 ~ 121.
8Luo Y, Ma D, Leong E, et al. Xenon and seveflurane pro- tect against brain injury in a neonatal asphyxia model[J]. Anesthesiology, 2008,109 (5) : 782.
9De Hert S, Preckel B, Schlack WS. Update on inhalational anaesthetics[J]. Current Opinion in Anaesthesiology, 2009,22(4) :491.
10Naguib M.Sugammadex: another milestone in clinical neu- romuscular pharmacology[J]. Anesthesia Analgesia, 2007, 104(3):575.
